Zai Lab (ZLAB) Shares Outstanding (2016 - 2026)
Zai Lab (ZLAB) posted Shares Outstanding (Entity) of $1.1 billion for Q1 2026, little changed sequentially from $1.1 billion in Q4 2025, and up 2.73% YoY from $1.1 billion in Q1 2025.
Zai Lab (ZLAB) Shares Outstanding (2016 - 2026) Analysis & Trends
Zai Lab has reported Shares Outstanding (Entity) for 11 years, with the latest figure at $1.1 billion in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 2.73% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 2.73% YoY) and the FY2025 annual result came in at $1.1 billion, up 2.88% from the prior year.
- Shares Outstanding (Entity) steadied at $1.1 billion in Q1 2026 per ZLAB's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $1.1 billion in Q1 2026 and troughed at $957.0 million in Q1 2022.
- A 5-year average of $1.0 billion and a median of $978.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) gained 0.74% in 2022, then climbed 12.54% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $962.5 million in 2022, then rose by 1.53% to $977.2 million in 2023, then climbed by 10.79% to $1.1 billion in 2024, then gained by 2.88% to $1.1 billion in 2025, then climbed by 0.45% to $1.1 billion in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 1.12 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.10 Bn |
| Sep 30, 2025 | 1.10 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Mar 31, 2025 | 1.08 Bn |
| Dec 31, 2024 | 989.48 Mn |
| Sep 30, 2024 | 981.69 Mn |
| Jun 30, 2024 | 975.94 Mn |
| Mar 31, 2024 | 973.15 Mn |
| Dec 31, 2023 | 966.39 Mn |
| Sep 30, 2023 | 968.77 Mn |
| Jun 30, 2023 | 964.82 Mn |
| Mar 31, 2023 | 961.44 Mn |
| Dec 31, 2022 | 958.07 Mn |
| Sep 30, 2022 | 959.09 Mn |
| Jun 30, 2022 | 957.68 Mn |
| Mar 31, 2022 | 955.50 Mn |
| Dec 31, 2021 | 929.92 Mn |
| Sep 30, 2021 | 950.35 Mn |